Netflix ends anti-takeover measure two years early

Dec 30, 2013

Netflix says it's ending a move meant to help ward off hostile takeovers almost two years early.

The online video company adopted the shareholder rights plan, also known as a poison pill, in November 2012 after activist investor Carl Icahn disclosed a stake of almost 10 percent in the company.

The poison pill was scheduled to expire in November 2015, but the company terminated it effective Monday.

According to FactSet, Icahn now owns a 4.5 percent stake in Netflix Inc.

Netflix stock fell 51 cents to close at $366.99 on Monday. The Los Gatos, Calif.-based company's shares have nearly quadrupled in value this year.

Explore further: PayPal buys money-sending service Xoom in $890 mn deal

Related Stories

Netflix moves to block a hostile takeover (Update)

Nov 05, 2012

(AP)—Netflix is moving to protect itself against hostile takeovers, less than a week after activist investor Carl Icahn disclosed that he has accumulated a stake of nearly 10 percent in the online video ...

Carl Icahn's stake in Nuance grows to 16.9 pct.

Sep 01, 2013

Billionaire investor Carl Icahn has raised his stake in Nuance Communications over the past month to almost 17 percent, nearing a threshold that would trigger defensive mechanisms to thwart a hostile takeover.

Southeastern takes 12 pct stake in News Corp.

Sep 11, 2013

Southeastern Asset Management Inc., the investment firm that along with activist investor Carl Icahn opposed the proposed buyout of Dell Inc., disclosed that it has taken a nearly 12 percent stake in News Corp.

Recommended for you

Barnes & Noble names Sears Canada CEO for retail business

2 hours ago

Barnes & Noble, which is splitting into two companies next month, named Sears Canada CEO Ronald Boire to lead its retail operations and said company CEO Michael Huseby will become executive chairman its educational wing.

Hewlett-Packard moves forward with plan to split in two

17 hours ago

Hewlett-Packard is moving forward with plans to split into two companies, filing paperwork to create a new entity that will sell commercial technology, while a separate spinoff will sell personal computers and printers.

Global pharma firms grilled about tax in Australia

Jul 01, 2015

The world's top pharmaceutical companies Wednesday told an Australian parliamentary hearing they were compliant with local and international laws, despite claims they are charging higher prices to minimise tax.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.